.Nature Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for addition of individuals along with MASLD and also measurement of liver outcomes in cardio-- kidney-- metabolic trials, when records suggest mechanistically tenable benefits as well as scientific security-- as well as describes considerations for trial layout and also governing commendation.